Dr. Ryo Kawakami graduated from Kagawa University School of Medicine in Kagawa, Japan in 2007. He started his career as a physician at Kagawa University Hospital where he specialized in Cardiology after two years of general training. In 2009, he entered into the Department of CardioRenal and Cerebrovascular Medicine at Kagawa University. He worked on research projects of atherosclerosis that included lipid metabolism and the effects of cardiac exercise training on cardiovascular diseases, besides his activities as a clinical researcher. In 2016, he joined at the group of Prof. Ryuichi Morishita at the Department of Clinical Gene Therapy, Osaka University. There he investigated the lipid mechanism and its clinical translation to develop a therapeutic vaccine for dyslipidemia. He has experienced various cardiovascular diseases as an Assistant Professor in the Department of CardioRenal and Cerebrovascular Medicine at Kagawa University from 2014 where he was funded by Research Fund for subsidy of Kagawa University.
He started working as a research fellow in the Center for Excellence in Vascular Biology, Cardiovascular Medicine, at Brigham and Women’s Hospital on January 3, 2017.